Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Thrombosis and Haemostasis : JTH|July 24, 2008
Arterial antithrombotic and bleeding time effects of apixaban, a direct factor Xa inhibitor, in combination with antiplatelet therapy in rabbitsP C Wong, C A Watson, E J CrainJournal of Thrombosis and Haemostasis : JTH|June 9, 2009
Favorable therapeutic index of the direct factor Xa inhibitors, apixaban and rivaroxaban, compared with the thrombin inhibitor dabigatran in rabbitsP C Wong, E J Crain, C A Watson, et al.Thrombosis Research|July 15, 1996
Antithrombotic actions of selective inhibitors of blood coagulation factor Xa in rat models of thrombosisP C Wong, E J Crain, O Nguan, et al.The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Nonpeptide factor Xa inhibitors: I. Studies with SF303 and SK549, a new class of potent antithromboticsP C Wong, M L Quan, E J Crain, et al.Journal of Thrombosis and Haemostasis : JTH|March 5, 2008
Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studiesP C Wong, E J Crain, B Xin, et al.The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Nonpeptide factor Xa inhibitors II. Antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosisP C Wong, E J Crain, R M Knabb, et al.Journal of Cardiovascular Pharmacology|September 1, 1995
Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtypeP C Wong, M L Quan, J M Saye, et al.Pageof 1